Exploring Potentilla nepalensis Phytoconstituents: Integrated Strategies of Network Pharmacology, Molecular Docking, Dynamic Simulations, and MMGBSA Analysis for Cancer Therapeutic Targets Discovery
Pharmaceuticals · 19.01.2024 · 17 (1) · 134
DOI: 10.3390/ph17010134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.01.2024. Verfasst von Mallari Praveen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Indira Gandhi National Tribal University, Amarkantak 484886, India. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Potentilla nepalensis belongs to the Rosaceae family and has numerous therapeutic applications as potent plant-based medicine. Forty phytoconstituents (PCs) from the root and stem through n-hexane (NR and NS) and methanolic (MR and MS) extracts were identified in earlier studies. However, the PCs affecting human genes and their roles in the body have not previously been disclosed. In this study, we employed network pharmacology, molecular docking, molecular dynamics simulations (MDSs), and MMGBSA methodologies. The SMILES format of PCs from the PubChem was used as input to DIGEP-Pred, with 764 identified as the inducing genes. Their enrichment studies have shown inducing genes’ gene ontology descriptions, involved pathways, associated diseases, and drugs. PPI networks constructed in String DB and network topological analyzing parameters performed in Cytoscape v3.10 revealed three therapeutic targets: TP53 from MS-, NR-, and NS-induced genes; HSPCB and Nf-kB1 from MR-induced genes. From 40 PCs, two PCs, 1b (MR) and 2a (MS), showed better binding scores (kcal/mol) with p53 protein of −8.6 and −8.0, and three PCs, 3a, (NR) 4a, and 4c (NS), with HSP protein of −9.6, −8.7, and −8.2. MDS and MMGBSA revealed these complexes are stable without higher deviations with better free energy values. Therapeutic targets identified in this study have a prominent role in numerous cancers. Thus, further investigations such as in vivo and in vitro studies should be carried out to find the molecular functions and interlaying mechanism of the identified therapeutic targets on numerous cancer cell lines in considering the PCs of P. nepalensis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Zoology, Indira Gandhi National Tribal University, Amarkantak 484886, India.
- Institute of Chemical Sciences, University of Swat, Main Campus, Charbagh 19130, Pakistan.
- Department of Chemical Biological Sciences, Universidad de las Américas Puebla, Puebla 72810, Mexico.
- Department of Chemistry, Government College University, Faisalabad 38000, Pakistan.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
ORCID-Profile: Mallari Praveen, Mian Gul Sayed, Mashooq Ahmad Bhat, Muhammad Yaseen
Förderung
- King Saud University
Zitieren
APA
Praveen, M., Ullah, I., Buendia, R., Khan, I. A., Sayed, M. G., Kabir, R., Bhat, M. A., & Yaseen, M. (2024). Exploring Potentilla nepalensis Phytoconstituents: Integrated Strategies of Network Pharmacology, Molecular Docking, Dynamic Simulations, and MMGBSA Analysis for Cancer Therapeutic Targets Discovery. Pharmaceuticals, 17(1), 134. https://doi.org/10.3390/ph17010134
Vancouver
Praveen M, Ullah I, Buendia R, Khan IA, Sayed MG, Kabir R, et al. Exploring Potentilla nepalensis Phytoconstituents: Integrated Strategies of Network Pharmacology, Molecular Docking, Dynamic Simulations, and MMGBSA Analysis for Cancer Therapeutic Targets Discovery. Pharmaceuticals. 2024;17(1):134. doi:10.3390/ph17010134
BibTeX
@article{Praveen2024,
author = {Praveen, Mallari and Ullah, Ihsan and Buendia, Ricardo and Khan, Imran Ahmad and Sayed, Mian Gul and Kabir, Rahmul and Bhat, Mashooq Ahmad and Yaseen, Muhammad},
title = {Exploring Potentilla nepalensis Phytoconstituents: Integrated Strategies of Network Pharmacology, Molecular Docking, Dynamic Simulations, and MMGBSA Analysis for Cancer Therapeutic Targets Discovery},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {1},
pages = {134},
doi = {10.3390/ph17010134}
}
EUVIMED